AJMC November 10, 2023
In a recent review, researchers overviewed the challenging aspects of treating pulmonary arterial hypertension (PAH), highlight the genetic and etiological variability, and advocate for research to expand personalized medicine.
A review article published in Pulmonary Circulation explored the multitude of obstacles hindering adequate treatment for patients with pulmonary arterial hypertension (PAH). The overview emphasizes the intricate nature of treatment approaches for this population that vary depending on interactions between genetic, sex, racial and ethnic, etiological, and pharmacological response factors.
Currently, there is no cure for PAH other than a complete lung transplant. While this constitutes a great challenge in the realm of PAH, an equally great challenge occurs in physicians’ abilities to predict the most beneficial treatment methods for their...
Today's Sponsors
Today's Sponsor